Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Randall, T. C.
Right arrow Articles by Armstrong, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Randall, T. C.
Right arrow Articles by Armstrong, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 21, Issue 22 (November), 2003: 4200-4206
© 2003 American Society for Clinical Oncology

Differences in Treatment and Outcome Between African-American and White Women With Endometrial Cancer

Thomas C. Randall, Katrina Armstrong

From the Departments of Obstetrics and Gynecology and Medicine, and the Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine; Abramson Cancer Center and Leonard Davis Institute of Health Economics, University of Pennsylvania; and Center for Health Equity Research and Promotion, Philadelphia, PA.

Address reprint requests to Katrina Armstrong, MD, MSCE, 1204 Blockley Hall, 423 Guardian Dr, Philadelphia, PA 19104-6021; e-mail: karmstro{at}mail.med.upenn.edu.

Purpose: To investigate disparities in treatment and outcomes between African-American and white women with endometrial cancer.

Patients and Methods: We analyzed 1992 to 1998 Surveillance, Epidemiology, and End Results data for 21,561 women with epithelial cancers of the endometrium. Sequential Cox proportional hazard models were used to determine the association between tumor characteristics (stage, grade, and histologic type), sociodemographic characteristics (age and marital status), and treatment (surgery and radiation therapy) and the racial difference in mortality.

Results: The unadjusted hazard ratio (HR) for death from endometrial cancer for African-American women compared with white women was 2.57. However, African-American women were significantly more likely to present with advanced-stage disease and have poorly differentiated tumors or tumors with an unfavorable histologic type and were significantly less likely to undergo definitive surgery at all stages of disease. Adjusting for tumor and sociodemographic characteristics lowered the HR for African-American women to 1.80. Further adjustment for the use of surgery reduced the HR to 1.51. The association between surgery and survival was stronger among white women (HR, 0.26) than among African-American women (HR, 0.44).

Conclusion: African-American women with endometrial cancer are significantly less likely to undergo primary surgery and have significantly shorter survival than white women with endometrial cancer. Racial differences in treatment are associated with racial differences in survival. The association between use of surgery and survival is weaker among African-American than white women, raising questions about potential racial differences in the effectiveness of surgery.

K.A. is supported by a Robert Wood Johnson Generalist Physician Faculty Scholar Award and an American Cancer Society Clinical Research Training Grant.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Arch SurgHome page
E. C. Paulson, J. Ra, K. Armstrong, C. Wirtalla, F. Spitz, and R. R. Kelz
Underuse of Esophagectomy as Treatment for Resectable Esophageal Cancer
Arch Surg, December 1, 2008; 143(12): 1198 - 1203.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G. F. Fleming
Systemic Chemotherapy for Uterine Carcinoma: Metastatic and Adjuvant
J. Clin. Oncol., July 10, 2007; 25(20): 2983 - 2990.
[Full Text] [PDF]


Home page
American Behavioral ScientistHome page
G. L. Kreps
Communication and Racial Inequities in Health Care
American Behavioral Scientist, February 1, 2006; 49(6): 760 - 774.
[Abstract] [PDF]


Home page
JCOHome page
E. W. Steyerberg, C. C. Earle, B. A. Neville, and J. C. Weeks
Racial Differences in Surgical Evaluation, Treatment, and Outcome of Locoregional Esophageal Cancer: A Population-Based Analysis of Elderly Patients
J. Clin. Oncol., January 20, 2005; 23(3): 510 - 517.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2003 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online